Chromatin Regulation of KSHV Primary Infection
KSHV 原发感染的染色质调控
基本信息
- 批准号:8874167
- 负责人:
- 金额:$ 15.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-05-08 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:Antiviral AgentsB-LymphocytesBinding SitesCSPG6 geneCell divisionCellsChromatinChromatin ModelingChromatin StructureChromosome StructuresChromosomesDAXX geneDNADataDiseaseEndothelial CellsEnvironmentEpigenetic ProcessEquilibriumEventGene ExpressionGenetic TranscriptionGenomeGenome StabilityHumanHuman Herpesvirus 8Immediate-Early GenesImmediate-Early ProteinsInfectionInstructionKaposi SarcomaLymphomaLyticMaintenanceMalignant NeoplasmsMediatingMethodsModificationMolecularMolecular ConformationMulticentric Angiofollicular Lymphoid HyperplasiaPatternPlayPleural effusion disorderProteinsPublishingRegulationRoleSiteStagingTherapeutic InterventionTranscriptional RegulationViralViral GenesWorkchromatin remodelingcohesincohesionconnective tissue growth factordriving forceepigenomegammaherpesvirusgenome-widehistone modificationinsightlatent infectionprogramstransmission processvirus host interaction
项目摘要
PROJECT SUMMARY
(See instructions):
KSHV is a human gammaherpesvirus that is the causative agent of Kaposi's sarcoma (KS), and tightly associated with pleural effusion lymphoma (PEL) and multicentric Castleman's disease (MCD). Establishment of latent infection in B-lymphocytes and persistent infection in endothelial cells is thought to be a major driving force for KSHV-associated disease. Establishment of latent infection requires the formation of a stable circular minichromosome that expresses a limited set of viral genes. The mechanisms that establish minichromosome formation and restrict gene expression to the latency class are not well understood. Our previously published studies indicate that chromatin boundary factors, like CTCF, organize viral chromosome structure and histone modification patterns important for genome stability and restricted gene expression. CTCF interacts with cohesins (e.g. SMCl, SMC3, Rad21) to form higher order DNA conformations that are important for chromosome transmission during cell division and for coordinated transcription regulation. Recent studies from our group revealed that CTCF-cohesins mediate Interactions between the latent and lytic control regions of KSHV genomes in latently infected PEL cells. New preliminary data indicate that lytic immediate early genes are coordinately regulated through a chromatin structure involving CTCF and cohesins, and that cohesins are required for suppression of lytic gene transcription. Furthermore, CTCF binding sites are located in close proximity to RBP-jK sites at the lytic and latent control regions. Since RBP-jK is a primary target of KSHV immediate early protein Rta and latency maintenance protein LANA, we will explore how these proteins (e.g. RBP-jK, Rta, K8, and LANA) may interact with arid regulate CTGF-cohesion function. We will also investigate the role of host intrinsic defense proteins in regulating viral chromatin assembly. Finally, we will explore the role of LANA and KSHV infection on viral and host chromosome structure and epigenetic: modifications. These aims will synergize with projects 1 & 2 of this program project, and provide both molecular and genome-wide analyses of chromatin control mechanisms during the early stages of KSHV infection and in the establishment of KSHV latency.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL M LIEBERMAN其他文献
PAUL M LIEBERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL M LIEBERMAN', 18)}}的其他基金
Project 4: Regulation of EBV Latency and Oncogenesis by Hypoxia
项目4:缺氧对EBV潜伏期和肿瘤发生的调节
- 批准号:
10714176 - 财政年份:2023
- 资助金额:
$ 15.52万 - 项目类别:
Epigenomic Drivers of EBV Epithelial Cancers
EB 病毒上皮癌的表观基因组驱动因素
- 批准号:
10627690 - 财政年份:2023
- 资助金额:
$ 15.52万 - 项目类别:
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
针对 EB 病毒上皮癌的表观遗传和代谢控制
- 批准号:
10627689 - 财政年份:2023
- 资助金额:
$ 15.52万 - 项目类别:
EBNA1 Inhibitor for Treatment of EBV-positive DLBCL
EBNA1 抑制剂用于治疗 EBV 阳性 DLBCL
- 批准号:
10719866 - 财政年份:2023
- 资助金额:
$ 15.52万 - 项目类别:
Drugging EBNA1 to Treat EBV-Associated Cancers - Diversity Supplement
使用 EBNA1 药物治疗 EBV 相关癌症 - Diversity Supplement
- 批准号:
10818976 - 财政年份:2021
- 资助金额:
$ 15.52万 - 项目类别:
Drugging EBNA1 to Treat EBV-Associated Cancers
药物 EBNA1 治疗 EBV 相关癌症
- 批准号:
10185459 - 财政年份:2021
- 资助金额:
$ 15.52万 - 项目类别:
Regulation of EBV Latency by Purine Metabolism and Signaling
通过嘌呤代谢和信号传导调节 EBV 潜伏期
- 批准号:
10298045 - 财政年份:2021
- 资助金额:
$ 15.52万 - 项目类别:
相似海外基金
Characterizing RNA regulation in B lymphocytes
B 淋巴细胞中 RNA 调控的特征
- 批准号:
502601 - 财政年份:2024
- 资助金额:
$ 15.52万 - 项目类别:
Characterization of Streptococcus suis interactions with B lymphocytes
猪链球菌与 B 淋巴细胞相互作用的表征
- 批准号:
573206-2022 - 财政年份:2022
- 资助金额:
$ 15.52万 - 项目类别:
University Undergraduate Student Research Awards
Altered B lymphocytes Due to Tungstate Exposure
钨酸盐暴露导致 B 淋巴细胞发生改变
- 批准号:
RGPIN-2020-05899 - 财政年份:2022
- 资助金额:
$ 15.52万 - 项目类别:
Discovery Grants Program - Individual
The regulation of signaling and cytoskeletal rearrangements in B-lymphocytes
B 淋巴细胞信号传导和细胞骨架重排的调节
- 批准号:
RGPIN-2019-04911 - 财政年份:2022
- 资助金额:
$ 15.52万 - 项目类别:
Discovery Grants Program - Individual
Myocardial-associated B lymphocytes and inflammatory injury
心肌相关B淋巴细胞与炎症损伤
- 批准号:
10543825 - 财政年份:2022
- 资助金额:
$ 15.52万 - 项目类别:
Myocardial-associated B lymphocytes and inflammatory injury
心肌相关B淋巴细胞与炎症损伤
- 批准号:
10339541 - 财政年份:2022
- 资助金额:
$ 15.52万 - 项目类别:
Exploring RNA helicase DDX the role of the1 at the crossroad of DNA repair processes in B lymphocytes
探索 RNA 解旋酶 DDX 在 B 淋巴细胞 DNA 修复过程十字路口的作用
- 批准号:
BB/X511560/1 - 财政年份:2022
- 资助金额:
$ 15.52万 - 项目类别:
Training Grant
Role and regulation of extracellular vesicles generated in response to stimulation of CD24 on B lymphocytes
B 淋巴细胞上 CD24 刺激产生的细胞外囊泡的作用和调节
- 批准号:
RGPIN-2022-03800 - 财政年份:2022
- 资助金额:
$ 15.52万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




